The possible role of the kynurenine pathway in anhedonia in adolescents

Journal of Neural Transmission

Volumn 119, Issue 2, 2012, Pages 253-260

  Gabbay, Vilma ^a,b   Ely, Benjamin A ^a   Babb, James ^a   Liebes, Leonard ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adolescents; Anhedonia; Indoleamine 2,3 dioxygenase; Kynurenine pathway; Major depressive disorder

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE;

ADOLESCENT; ANHEDONIA; ARTICLE; CLINICAL ARTICLE; DIET RESTRICTION; DISEASE SEVERITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR DEPRESSION; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; SEMI STRUCTURED INTERVIEW;

ADOLESCENT; ANHEDONIA; BIOLOGICAL MARKERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; KYNURENINE; MALE; NEURAL PATHWAYS; YOUNG ADULT;

EID: 84857627727     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0685-7     Document Type: Article

References (55)

1. L Amori P Guidetti R Pellicciari Y Kajii R Schwarcz 2009 On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo J Neurochem 109 2 316 325 19226371 10.1111/j.1471-4159.2009.05893.x 1:CAS:528:DC%2BD1MXksVKgtbg%3D
2. IM Anderson M Parry-Billings EA Newsholme JR Poortmans PJ Cowen 1990 Decreased plasma tryptophan concentration in major depression: relationship to melancholia and weight loss J Affect Disord 20 3 185 191 2148339 10.1016/0165-0327(90)90143-V 1:STN:280:DyaK3M%2FptlGjsA%3D%3D (Pubitemid 20350931)
3. DM Araujo SR Cherry KJ Tatsukawa T Toyokuni HI Kornblum 2000 Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease Exp Neurol 166 2 287 297 11085894 10.1006/exnr.2000.7514 1:CAS:528:DC%2BD3cXotFCrsLg%3D
4. Badawy AB (2009) Plasma free tryptophan revisited: what you need to know and do before measuring it. J Psychopharmacol 24:809-815
5. HJ Ball HJ Yuasa CJ Austin S Weiser NH Hunt 2009 Indoleamine 2, 3-dioxygenase-2; a new enzyme in the kynurenine pathway Int J Biochem Cell Biol 41 3 467 471 18282734 10.1016/j.biocel.2008.01.005 1:CAS:528: DC%2BD1MXns1OrsQ%3D%3D
6. AT Beck D Guth RA Steer R Ball 1997 Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care Behav Res Ther 35 8 785 791 9256522 10.1016/S0005-7967(97)00025-9 1:STN:280:DyaK2svgtVKgtA%3D%3D (Pubitemid 27336913)
7. M Beskid L Finkiewicz-Murawiejska 1992 Quinolinic acid: effects on brain catecholamine and c-AMP content during l-dopa and reserpine administration Exp Toxicol Pathol 44 2 66 69 1319782 10.1016/S0940-2993(11)80189-2 1:CAS:528:DyaK38XlvVKhs7s%3D
8. A Boasso JP Herbeuval AW Hardy C Winkler GM Shearer 2005 Regulation of indoleamine 2, 3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells Blood 105 4 1574 1581 15466932 10.1182/blood-2004-06-2089 1:CAS:528:DC%2BD2MXhsVChtbs%3D (Pubitemid 40223677)
9. S Bonaccorso V Marino A Puzella M Pasquini M Biondi M Artini C Almerighi R Verkerk H Meltzer M Maes 2002 Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system J Clin Psychopharmacol 22 1 86 90 11799348 10.1097/00004714-200202000-00014 1:CAS:528:DC%2BD38Xht1yku7c%3D (Pubitemid 34101297)
10. L Capuron G Neurauter DL Musselman DH Lawson CB Nemeroff D Fuchs AH Miller 2003 Interferon-alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment Biol Psychiatry 54 9 906 914 14573318 10.1016/S0006-3223(03)00173-2 1:CAS:528:DC%2BD3sXot1Omt78%3D (Pubitemid 37311353)
11. L Capuron G Pagnoni MF Demetrashvili DH Lawson FB Fornwalt B Woolwine GS Berns CB Nemeroff AH Miller 2007 Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy Neuropsychopharmacology 32 11 2384 2392 17327884 10.1038/sj.npp.1301362 1:CAS:528:DC%2BD2sXhtFOjtL3M (Pubitemid 47587675)
12. L Capuron CL Raison DL Musselman DH Lawson CB Nemeroff AH Miller 2003 Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy Am J Psychiatry 160 7 1342 1345 12832253 10.1176/appi.ajp.160.7.1342 (Pubitemid 41070955)
13. L Capuron A Ravaud PJ Neveu AH Miller M Maes R Dantzer 2002 Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy Mol Psychiatry 7 5 468 473 12082564 10.1038/sj.mp.4000995 1:CAS:528:DC%2BD38XkslKmtr8%3D (Pubitemid 34712898)
14. PJ Cowen M Parry-Billings EA Newsholme 1989 Decreased plasma tryptophan levels in major depression J Affect Disord 16 1 27 31 2521647 10.1016/0165-0327(89)90051-7 1:STN:280:DyaL1M7isVWgtg%3D%3D (Pubitemid 19020852)
15. G Curzon PK Bridges 1970 Tryptophan metabolism in depression J Neurol Neurosurg Psychiatry 33 5 698 704 5478953 10.1136/jnnp.33.5.698 1:CAS:528:DyaE3MXltFGmuw%3D%3D
16. NI Eisenberger ET Berkman TK Inagaki LT Rameson NM Mashal MR Irwin 2010 Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward Biol Psychiatry 68 8 748 754 20719303 10.1016/j.biopsych.2010.06.010 1:CAS:528:DC%2BC3cXht1ersrjI
17. S Erhardt SK Olsson G Engberg 2009 Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders CNS Drugs 23 2 91 101 19173370 10.2165/00023210-200923020-00001 1:CAS:528: DC%2BD1MXjslKrtr8%3D
18. V Gabbay RG Klein CM Alonso JS Babb M Nishawala G De Jesus GS Hirsch PM Hottinger-Blanc CJ Gonzalez 2009 Immune system dysregulation in adolescent major depressive disorder J Affect Disord 115 1-2 177 182 18790541 10.1016/j.jad.2008.07.022
19. V Gabbay RG Klein LE Guttman JS Babb CM Alonso M Nishawala Y Katz MR Gaite CJ Gonzalez 2009 A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression J Child Adolesc Psychopharmacol 19 4 423 430 19702494 10.1089/cap.2008.0140
20. Gabbay V, Klein RG, Katz Y, Mendoza S, Guttman LE, Alonso CM, Babb JS, Hirsch GS, Liebes L (2010a) The possible role of the kynurenine pathway in adolescent depression with melancholic features. J Child Psychol Psychiatry 51(8):935-943
21. V Gabbay L Liebes Y Katz S Liu S Mendoza JS Babb RG Klein O Gonen 2010 The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study Prog Neuropsychopharmacol Biol Psychiatry 34 1 37 44 19778568 10.1016/j.pnpbp.2009.09.015 1:CAS:528:DC%2BC3cXjvVShtg%3D%3D
22. LE Goldstein MC Leopold X Huang CS Atwood AJ Saunders M Hartshorn JT Lim KY Faget JA Muffat RC Scarpa LT Chylack Jr EF Bowden RE Tanzi AI Bush 2000 3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction Biochemistry 39 24 7266 7275 10852726 10.1021/bi992997s 1:CAS:528:DC%2BD3cXjsFSntbY%3D (Pubitemid 30413117)
23. S Hayley 2011 Toward an anti-inflammatory strategy for depression Front Behav Neurosci 5 19 21559062 10.3389/fnbeh.2011.00019
24. CJ Henry Y Huang A Wynne M Hanke J Himler MT Bailey JF Sheridan JP Godbout 2008 Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia J Neuroinflammation 5 15 18477398 10.1186/1742-2094-5-15 (Pubitemid 351803827)
25. MP Heyes RJ Ellis L Ryan ME Childers I Grant T Wolfson S Archibald TL Jernigan 2001 Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection Brain 124 Pt 5 1033 1042 11335705 10.1093/brain/124.5.1033 1:STN:280:DC%2BD3M3ptV2rsQ%3D%3D (Pubitemid 32458515)
26. MR Irwin AH Miller 2007 Depressive disorders and immunity: 20 years of progress and discovery Brain Behav Immun 21 4 374 383 17360153 10.1016/j.bbi.2007.01.010 1:CAS:528:DC%2BD2sXjvFOlsb4%3D (Pubitemid 46528684)
27. TE Joiner JS Brown GI Metalsky 2003 A test of the tripartite model's prediction of anhedonia's specificity to depression: patients with major depression versus patients with schizophrenia Psychiatry Res 119 3 243 250 12914895 10.1016/S0165-1781(03)00131-8 (Pubitemid 36952604)
28. J Kaufman B Birmaher D Brent U Rao C Flynn P Moreci D Williamson N Ryan 1997 Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data J Am Acad Child Adolesc Psychiatry 36 7 980 988 9204677 10.1097/00004583-199707000-00021 1:STN:280:DyaK2szkvVKqsQ%3D%3D (Pubitemid 27272932)
29. IP Kema EG de Vries FA Muskiet 2000 Clinical chemistry of serotonin and metabolites J Chromatogr B Biomed Sci Appl 747 1-2 33 48 11103898 10.1016/S0378-4347(00)00341-8 1:CAS:528:DC%2BD3cXmvFylu7o%3D
30. M Kubera AH Lin G Kenis E Bosmans D van Bockstaele M Maes 2001 Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio J Clin Psychopharmacol 21 2 199 206 11270917 10.1097/00004714-200104000-00012 1:CAS:528:DC%2BD3MXisV2qsb4%3D (Pubitemid 32221058)
31. M Kurachi T Sumiyoshi R Shibata YJ Sun T Uehara Y Tanii M Suzuki 2000 Changes in limbic dopamine metabolism following quinolinic acid lesions of the left entorhinal cortex in rats Psychiatry Clin Neurosci 54 1 83 89 15558884 10.1046/j.1440-1819.2000.00641.x 1:CAS:528:DC%2BD3cXos12htL0%3D (Pubitemid 30133699)
32. E Kwidzinski I Bechmann 2007 IDO expression in the brain: a double-edged sword J Mol Med 85 12 1351 1359 17594069 10.1007/s00109-007-0229-7 (Pubitemid 350234090)
33. AM Leventhal GS Chasson E Tapia EK Miller JW Pettit 2006 Measuring hedonic capacity in depression: a psychometric analysis of three anhedonia scales J Clin Psychol 62 12 1545 1558 17019674 10.1002/jclp.20327 (Pubitemid 44862645)
34. J Levine Y Barak KN Chengappa A Rapoport M Rebey V Barak 1999 Cerebrospinal cytokine levels in patients with acute depression Neuropsychobiology 40 4 171 176 10559698 10.1159/000026615 1:CAS:528: DyaK1MXotVCitLs%3D (Pubitemid 29515729)
35. D Lindqvist S Janelidze P Hagell S Erhardt M Samuelsson L Minthon O Hansson M Bjorkqvist L Traskman-Bendz L Brundin 2009 Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity Biol Psychiatry 66 3 287 292 19268915 10.1016/j.biopsych.2009.01.030 1:CAS:528:DC%2BD1MXotF2nsr0%3D
36. M Maes C Song AH Lin S Bonaccorso G Kenis R De Jongh E Bosmans S Scharpe 1999 Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion Neuropsychopharmacology 20 4 370 379 10088138 10.1016/S0893-133X(98)00088-8 1:CAS:528:DyaK1MXitVSnur4%3D (Pubitemid 29099768)
37. M Maes A Wauters R Verkerk P Demedts H Neels A Van Gastel P Cosyns S Scharpe R Desnyder 1996 Lower serum l-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism Neuropsychopharmacology 15 3 243 251 8873107 10.1016/0893-133X(95)00181-C 1:CAS:528:DyaK28Xls1alt7c%3D (Pubitemid 26285654)
38. M Majer LA Welberg L Capuron G Pagnoni CL Raison AH Miller 2008 IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C Brain Behav Immun 22 6 870 880 18258414 10.1016/j.bbi.2007.12.009 1:CAS:528:DC%2BD1cXotlGjtLY%3D
39. L McNally Z Bhagwagar J Hannestad 2008 Inflammation, glutamate, and glia in depression: a literature review CNS Spectr 13 6 501 510 18567974 (Pubitemid 351965454)
40. AH Miller 2009 Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface Brain Behav Immun 23 2 149 158 18793712 10.1016/j.bbi.2008.08.006 1:CAS:528: DC%2BD1MXhtFSnt70%3D
41. M Moreau C Andre JC O'Connor SA Dumich JA Woods KW Kelley R Dantzer J Lestage N Castanon 2008 Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior Brain Behav Immun 22 7 1087 1095 18479887 10.1016/j.bbi.2008.04.001 1:CAS:528:DC%2BD1cXhtVOiu7bJ
42. MF Murray 2007 The human indoleamine 2, 3-dioxygenase gene and related human genes Curr Drug Metab 8 3 197 200 17430106 10.2174/138920007780362509 1:CAS:528:DC%2BD2sXks1Kiu7k%3D (Pubitemid 46621669)
43. AM Myint YK Kim R Verkerk S Scharpe H Steinbusch B Leonard 2007 Kynurenine pathway in major depression: evidence of impaired neuroprotection J Affect Disord 98 1-2 143 151 16952400 10.1016/j.jad.2006.07.013 1:CAS:528:DC%2BD2sXmtVWhtg%3D%3D (Pubitemid 46048912)
44. O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R (2008) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14(5):511-522
45. S Okuda N Nishiyama H Saito H Katsuki 1998 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity J Neurochem 70 1 299 307 9422375 10.1046/j.1471-4159.1998.70010299.x 1:CAS:528:DyaK1cXmt1Wk (Pubitemid 28020856)
46. DA Pizzagalli AL Jahn JP O'Shea 2005 Toward an objective characterization of an anhedonic phenotype: a signal-detection approach Biol Psychiatry 57 4 319 327 15705346 10.1016/j.biopsych.2004.11.026 (Pubitemid 40215760)
47. Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, Spivey JR, Saito K, Miller AH (2009) CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 15(4):393-403
48. K Schrocksnadel B Wirleitner C Winkler D Fuchs 2006 Monitoring tryptophan metabolism in chronic immune activation Clin Chim Acta 364 1-2 82 90 16139256 10.1016/j.cca.2005.06.013 (Pubitemid 43120630)
49. R Schwarcz R Pellicciari 2002 Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities J Pharmacol Exp Ther 303 1 1 10 12235226 10.1124/jpet.102.034439 1:CAS:528:DC%2BD38XnsV2ru7k%3D
50. R Schwarcz WO Whetsell Jr RM Mangano 1983 Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain Science 219 4582 316 318 6849138 10.1126/science.6849138 1:CAS:528:DyaL3sXmvF2gsQ%3D%3D (Pubitemid 13222319)
51. H Shuto Y Kataoka T Horikawa N Fujihara R Oishi 1997 Repeated interferon-alpha administration inhibits dopaminergic neural activity in the mouse brain Brain Res 747 2 348 351 9046014 10.1016/S0006-8993(96)01371-6 1:CAS:528:DyaK2sXnsFymtA%3D%3D (Pubitemid 27077413)
52. T Sumiyoshi M Tsunoda T Uehara K Tanaka H Itoh C Sumiyoshi M Kurachi 2004 Enhanced locomotor activity in rats with excitotoxic lesions of the entorhinal cortex, a neurodevelopmental animal model of schizophrenia: behavioral and in vivo microdialysis studies Neurosci Lett 364 2 124 129 15196692 10.1016/j.neulet.2004.04.027 1:CAS:528:DC%2BD2cXkvVKqs78%3D (Pubitemid 38766180)
53. LK Tremblay CA Naranjo SJ Graham N Herrmann HS Mayberg S Hevenor UE Busto 2005 Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe Arch Gen Psychiatry 62 11 1228 1236 16275810 10.1001/archpsyc.62.11.1228 (Pubitemid 41586922)
54. MC Wichers GH Koek G Robaeys R Verkerk S Scharpe M Maes 2005 IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity Mol Psychiatry 10 6 538 544 15494706 10.1038/sj.mp.4001600 1:CAS:528:DC%2BD2MXksFejsb0%3D (Pubitemid 40897037)
55. HQ Wu R Schwarcz PD Shepard 1994 Excitatory amino acid-induced excitation of dopamine-containing neurons in the rat substantia nigra: modulation by kynurenic acid Synapse 16 3 219 230 7515199 10.1002/syn.890160307 1:CAS:528:DyaK2cXitV2iuro%3D (Pubitemid 24090248)